Trademark: 97133504
Word
AQOMTYC
Status Date
Monday, June 10, 2024
Filing Date
Friday, November 19, 2021
Published for Opposition
Tuesday, September 13, 2022
Abandoned Date
Monday, June 10, 2024
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives
Aug 8, 2022
Examiners Amendment E-Mailed
Nov 23, 2021
New Application Entered
Nov 24, 2021
New Application Office Supplied Data Entered
Aug 3, 2022
Assigned To Examiner
Aug 8, 2022
Examiners Amendment -Written
Aug 8, 2022
Notification Of Examiners Amendment E-Mailed
Aug 8, 2022
Examiner's Amendment Entered
Aug 8, 2022
Approved For Pub - Principal Register
Sep 13, 2022
Published For Opposition
Aug 24, 2022
Notification Of Notice Of Publication E-Mailed
Sep 13, 2022
Official Gazette Publication Confirmation E-Mailed
May 5, 2023
Sou Teas Extension Received
May 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2023
Sou Teas Extension Received
Nov 8, 2022
Noa E-Mailed - Sou Required From Applicant
May 5, 2023
Sou Extension 1 Filed
May 5, 2023
Sou Extension 1 Granted
Nov 7, 2023
Sou Extension 2 Filed
Nov 7, 2023
Sou Extension 2 Granted
Nov 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 10, 2024
Abandonment - No Use Statement Filed
Jul 12, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
